Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Trials
Published in: Trials 1/2017

Open Access 01-12-2017 | Study protocol

Effects of digital Cognitive Behavioural Therapy for Insomnia on cognitive function: study protocol for a randomised controlled trial

Published in: Trials | Issue 1/2017

Login to get access

Abstract

Background

The daytime effects of insomnia pose a significant burden to patients and drive treatment seeking. In addition to subjective deficits, meta-analytic data show that patients experience reliable objective impairments across several cognitive domains. While Cognitive Behavioural Therapy for Insomnia (CBT-I) is an effective and scalable treatment, we know little about its impact upon cognitive function. Trials of CBT-I have typically used proxy measures for cognitive functioning, such as fatigue or work performance scales, and no study has assessed self-reported impairment in cognitive function as a primary outcome. Moreover, only a small number of studies have assessed objective cognitive performance, pre-to-post CBT-I, with mixed results. This study specifically aims to (1) investigate the impact of CBT-I on cognitive functioning, assessed through both self-reported impairment and objective performance measures, and (2) examine whether change in sleep mediates this impact.

Methods/design

We propose a randomised controlled trial of 404 community participants meeting criteria for Insomnia Disorder. In the DISCO trial (D efining the I mpact of improved S leep on CO gnitive function (DISCO)) participants will be randomised to digital automated CBT-I delivered by a web and/or mobile platform (in addition to treatment as usual (TAU)) or to a wait-list control (in addition to TAU). Online assessments will take place at 0 (baseline), 10 (post-treatment), and 24 (follow-up) weeks. At week 25, all participants allocated to the wait-list group will be offered digital CBT-I, at which point the controlled element of the trial will be complete. The primary outcome is self-reported cognitive impairment at post-treatment (10 weeks). Secondary outcomes include objective cognitive performance, insomnia severity, sleepiness, fatigue, and self-reported cognitive failures and emotional distress. All main analyses will be carried out on completion of follow-up assessments and will be based on the intention-to-treat principle. Further analyses will determine to what extent observed changes in self-reported cognitive impairment and objective cognitive performance are mediated by changes in sleep. The trial is supported by the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) based at Oxford University Hospitals NHS Trust and University of Oxford, and by the NIHR Oxford Health BRC.

Discussion

This study will be the first large-scale examination of the impact of digital CBT-I on self-reported cognitive impairment and objective cognitive performance.

Trial registration

ISRCTN, ID: ISRCTN89237370. Registered on 17 October 2016.
Appendix
Available only for authorised users
Literature
1.
2.
3.
Kyle SD, Espie CA, Morgan K. Not just a minor thing, it is something major, which stops you from functioning daily’: quality of life and daytime functioning in insomnia. Behav Sleep Med. 2010;8(3):123–40.CrossRefPubMed
4.
Kyle SD, Morgan K, Espie CA. Insomnia and health-related quality of life. Sleep Med Rev. 2010;14(1):69–82.CrossRefPubMed
5.
Espie CA, Kyle SD, Hames P, Cyhlarova E, Benzeval M. The daytime impact of DSM-5 insomnia disorder: comparative analysis of insomnia subtypes from the Great British Sleep Survey. J Clin Psychiatry. 2012;73(12):1478–84.CrossRef
6.
Kyle SD, Crawford MR, Morgan K, Spiegelhalder K, Clark AA, Espie CA. The Glasgow Sleep Impact Index (GSII): a novel patient-centred measure for assessing sleep-related quality of life impairment in Insomnia Disorder. Sleep Med. 2013;14(6):493–501.CrossRefPubMed
7.
Fortier-Brochu É, Beaulieu-Bonneau S, Ivers H, Morin CM. Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev. 2012;16(1):83–94.CrossRefPubMed
8.
Shekleton JA, Flynn-Evans EE, Miller B, Epstein LJ, Kirsch D, Brogna LA, et al. Neurobehavioral performance impairment in insomnia: relationships with self-reported sleep and daytime functioning. Sleep. 2014;37(1):107–16. doi:10.​5665/​sleep.​3318.PubMedPubMedCentral
9.
10.
Altena E, Van Der Werf YD, Sanz-Arigita EJ, Voorn TA, Rombouts SA, Kuijer JP, et al. Prefrontal hypoactivation and recovery in insomnia. Sleep. 2008;31(9):1271–6.PubMedPubMedCentral
11.
Stoffers D, Altena E, van der Werf YD, Sanz-Arigita EJ, Voom TA, Astill RG, et al. The caudate: a key node in the neuronal network imbalance of insomnia? Brain. 2014;137(2):610–20.CrossRefPubMed
12.
13.
Spiegelhalder K, Regen W, Baglioni C, Nissen C, Riemann D, Kyle SD. Neuroimaging insights into insomnia. Curr Neurol Neurosci Rep. 2015;15(3):1–7.CrossRef
14.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington: American Psychiatric Association; 2013.CrossRef
15.
Herbert V, Kyle SD, Pratt D. Does cognitive behavioural therapy for insomnia improve cognitive performance? A systematic review and narrative synthesis. Sleep Med Rev.
16.
Leger D, Bayon V, Ohayon MM, Philip P, Ement P, Metlaine A, et al. Insomnia and accidents: cross-sectional study (EQUINOX) on sleep-related home, work and car accidents in 5293 subjects with insomnia from 10 countries. J Sleep Res. 2014;23(2):143–52.CrossRefPubMed
17.
Miro E, Lupianez J, Martinez MP, Sanchez AI, Diaz-Piedra C, Guzman MA, et al. Cognitive-behavioral therapy for insomnia improves attentional function in fibromyalgia syndrome: a pilot, randomized controlled trial. J Health Psychol. 2011;16(5):770–82.CrossRefPubMed
18.
Omvik S, Sivertsen B, Pallesen S, Bjorvatn B, Havik OE, Nordhus IH. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with zopiclone. Behav Res Ther. 2008;46(5):623–41.CrossRefPubMed
19.
Wilckens KA, Hall MH, Nebes RD, Monk TH, Buysse DJ. Changes in cognitive performance are associated with changes in sleep in older adults with insomnia. Behav Sleep Med. 2016;14(3):295–310.CrossRefPubMed
20.
Espie CA, Kyle SD, Williams C, Ong JC, Douglas NJ, Hames P, et al. A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application. Sleep. 2012;35(6):769–81. doi:10.​5665/​sleep.​1872.CrossRefPubMedPubMedCentral
21.
Seyffert M, Lagisetty P, Landgraf J, Chopra V, Pfeiffer PN, Conte ML, et al. Internet-delivered cognitive behavioural therapy to treat insomnia: a systematic review and meta-analysis. PLoS One. 2016;11(2):e0149139.CrossRefPubMedPubMedCentral
22.
Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of Internet-delivered cognitive-behavioural therapy for insomnia—A systematic review and meta-analysis of randomized controlled trials. Sleep Med Rev. 2016;30:1–10.CrossRefPubMed
23.
24.
Kyle SD, Morgan K, Espie CA. The Daytime Functioning and Sleep Attribution Scale (DFSAS): a new insomnia-specific measure to probe daytime impairment and poor sleep attributions. 2010. Sleep;33, A192–A193). One Westbrook Corporate Ctr., Ste. 920, Westchester, IL 60154 USA: American Academy of Sleep Medicine.
25.
Wilson SJ, Nutt DJ, Alford C, Argyropoulos SV, Baldwin DS, Bateson AN, et al. British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders. J Psychopharmacol. 2010;24(11):1577–600.CrossRefPubMed
26.
27.
28.
Espie C, Luik AI, Cape J, Drake CL, Niroshan Siriwardena A, Ong JC, et al. Digital cognitive behavioural therapy for insomnia versus sleep hygiene education: the impact of improved sleep on functional health, quality of life and psychological well-being. Study protocol for a randomised controlled trial. Trials. 2016;17:257. doi:10.​1186/​s13063-016-1364-7.CrossRefPubMedPubMedCentral
29.
Espie CA, Inglis SJ, Tessler S, Harvey L. The clinical effectiveness of cognitive behavior therapy for chronic insomnia: implementation and evaluation of a sleep clinic in general medical practice. Behav Res Ther. 2001;39:45–60.CrossRefPubMed
30.
Espie CA, MacMahon KM, Kelly HL, Broomfield NM, Douglas NJ, Engleman HM, et al. Randomized clinical effectiveness trial of nurse-administered small-group cognitive behavior therapy for persistent insomnia in general practice. Sleep. 2007;30:574–84.CrossRefPubMed
31.
Espie CA, Fleming L, Cassidy J, Samuel L, Taylor L, White C, et al. Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol. 2008;26:4651–8.CrossRefPubMed
32.
Iverson GL, Lam RW. Rapid screening for perceived cognitive impairment in major depressive disorder. Ann Clin Psychiatry. 2013;25(2):135–40.PubMed
33.
34.
Morin CM. Insomnia: psychological assessment and management. New York: Guilford Press; 1993.
35.
Buysse DJ, Ancoli-Israel S, Edinger JD, Lichstein KL, Morin CM. Recommendations for a standard research assessment of insomnia. Sleep. 2006;29:1155–73.CrossRefPubMed
36.
Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28(2):193–213.CrossRefPubMed
37.
Smets E, Garssen B, Bonke BD, De Haes J. The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res. 1995;39(3):315–25.CrossRefPubMed
38.
Johns MW. A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale. Sleep. 1991;14(6):540–5.CrossRefPubMed
39.
Broadbent DE, Cooper PF, FitzGerald P, Parkes KR. The Cognitive Failures Questionnaire (CFQ) and its correlates. Br J Clin Psychol. 1982;21(1):1–16.CrossRefPubMed
40.
Kroenke K, Spitzer RL, Williams JB, Löwe B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;32:345–59.
41.
Spitzer RL, Kroenke K, Williams JB, Löwe B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;16(10):1092–7.CrossRef
42.
Kyle SD, Morgan K, Spiegelhalder K, Espie CA. No pain, no gain: an exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Med. 2011;12(8):735–47.CrossRefPubMed
43.
Moher D, Hopwell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ, et al. CONSORT 2010 Explanation and Elaboration: updated guidelines for reporting parallel group randomised trials. BMJ. 2010;340:c869.CrossRefPubMedPubMedCentral
44.
StataCorp. Stata Statistical Software: Release 14. College Station: StataCorp LP; 2015.
Metadata
Title
Effects of digital Cognitive Behavioural Therapy for Insomnia on cognitive function: study protocol for a randomised controlled trial
Publication date
01-12-2017
Published in
Trials / Issue 1/2017
Electronic ISSN: 1745-6215
DOI
https://doi.org/10.1186/s13063-017-2012-6

Other articles of this Issue 1/2017

Trials 1/2017 Go to the issue

Research

Quality of intervention delivery in a cluster randomised controlled trial: a qualitative observational study with lessons for fidelity

Study protocol

Intranasal sedation using ketamine and midazolam for pediatric dental treatment (NASO): study protocol for a randomized controlled trial

Study protocol

Xingnaojing for Moderate-to-severe Acute ischemic Stroke (XMAS): study protocol for a randomized controlled trial

Methodology

Impact of a deferred recruitment model in a randomised controlled trial in primary care (CREAM study)

Research

Lessons from the field: the conduct of randomized controlled trials in Botswana

Research

BADERI: an online database to coordinate handsearching activities of controlled clinical trials for their potential inclusion in systematic reviews